Transfusion-transmitted protozoal infections: What is the risk in non-endemic countries?;Infecções parasitárias transmitidas por transfusão de sangue: Qual o risco nos países não endémicos?

Acta Medica Portuguesa

Volumn 24, Issue SUPPL.4, 2011, Pages 897-906

  Pereira, Branca Isabel ^a   Nazareth, Cláudia ^a   Malcata, Lurdes ^a   Alves, Helena ^a   Fernández, José Rafael ^a   Sargento, Celene ^a   da Cunha, Saraiva ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN TRYPANOSOMIASIS; BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION; CHAGAS DISEASE; ENDEMIC DISEASE; HUMAN; IMMIGRANT; IMMIGRATION; INFECTION RISK; LEISHMANIASIS; LOWEST INCOME GROUP; MALARIA; PARASITE TRANSMISSION; PORTUGAL; PROTOZOAL INFECTION; QUESTIONNAIRE; REVIEW; TOXOPLASMOSIS;

BLOOD TRANSFUSION; CHAGAS DISEASE; HUMANS; MALARIA; PROTOZOAN INFECTIONS; RISK ASSESSMENT;

EID: 84864489652     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Screening for infectious markers. In: Guide to the preparation, use and quality assurance of blood components. 10th ed. Strasbourg: Council of Europe Publishing 2004; 209-216
2. WORLD HEALTH ORGANIZATION (WHO): World Malaria Report 2008; 9
3. WOLLSEY G: Transfusion for pernicious anemia: two cases. Ann Surg 1911;53:132-5
4. BRUCE-CHWATT LJ: Transfusion malaria revisited. Trop Dis Bull 1982;79:827-40
5. MUNGAI M, TEGTMEIER G, CHAMBERLAND M, PARISE M: Transfusion-transmitted Malaria in the United States from 1963 through 1999. N Engl J Med 2001;344:1973-78
6. BRUNEEL F, THELLIER M, ELOY O, et al: Transfusion-transmitted malaria. Intensive Care Med 2004;30:1851-2
7. GARRAUD O: Mechanisms of transfusion-linked parasite infection. Transfus Clin Biol 2006;13:290-97
8. SEED CR, KITCHEN A, DAVIS T: The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev 2005;19;229-240
9. REESINK HW, ENGELFREIT CP: International Forum: Are current measures to prevent transfusion-associated protozoal infections sufficient? Vox Sang 2004;47:125-38
10. o 267/2007 de 24 de Julho de 2007
11. BENITO A, RUBIO JM: Usefulness of seminested polymerase chain reaction for screening blood donors at risk for malaria in Spain (letter). Emerg Infect Dis 2001;7:1068
12. HÄNSCHEID T, VALADAS E, GROBUSCH MP: Polymerase Chain Reaction for screening blood donors at risk for Malaria: safe and useful? (letter) Emerg Infect Dis 2001;8:872
13. Critérios de selecção de dadores. Sociedade Portuguesa de Imunonhemoterapia. Disponível em www.apih.eu
14. FERNÁNDEZ R. Epidemiologia dos anticorpos antipaludismo em dadores de sangue-efeitos no âmbito do decreto-lei 267/2007. AB0 2009 (suplemento);40:21-24
15. WORLD HEALTH ORGANIZATION (WHO): Chagas Disease-TDR strategic direction, February 2002
16. PRATA A: Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001;1:92-100
17. DIAS JP, BASTOS C, ARAÚJO E, et al: Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 2008;41(3):296-300
18. MAZZA S, MONTANA A, BENITEZ C, JANZY ES: Transmisión de Schizotrypanum cruzi al nino por leche de la madre con enfermedad de Chagas. Publ MEPRA 1936;28:41-46
19. MORAES-SOUZA H, BORDIN JO: Strategies for prevention of transfusion-associated Chagas disease. Transfus Med Rev 1996;3:161-70
20. ORGANIZAÇÃO PAN-AMERICANA DE SAÚDE (OPS)-Iniciativa del Cono Sur: VI Renión Intergubernamental para la eiminación da Triatoma infestans y la interrupción de la tripanosomiasis americana por transfusion. Documento OPS/HPC/HTC 98/102, 1997
21. PINTO DIAS JC. Enfermedad de Chagas: epidemiologia y control. Enfermedades emergentes 2005; 7(1):11-18
22. AMERICAN ASSOCIATION OF BLOOD BANK (AABB). Association bulletin 2206. Disponível em www.aabb.org
23. PÉREZ DE PEDRO I, MARTIN RICO P, SANTAMARIA S, et al: Caso clinico de Chagas transfusional. Emf Emerg 2008; 10 (supl 1):14-18
24. FLORES-CHÁVEZ M, FÉRNANDEZ B, PUENTe S, et al: Transfusional Chagas disease: parasitological and serological monitoring of an infected recipient and blood donor. CID 2008; 46:e44-47
25. RASSI AJR, RASSI A, MARIN-NETO JA: Chagas disease. Lancet. 2010 Apr 17;375:1388-402
26. GARRAUD O, ANDREU G, ELGHOUZZI MH, LAPERCHE S, LEFRERE JJ. Measures to prevent transfusion-associated protozoal infections in non-endemic countries. Travel Med Infect Dis 2007;5:110-12
27. WENDEL S: Transfusion-transmitted American and African trypanosomiasis: neglected or reality? ISBT Science Series 2006;1:140-51
28. QUEIRÓS L, NETO S, LEAL J, et al: Estudo epidemiológico da Doença de Chagas em dadores de sangue. AB0 Rev Med Transf 2010; 41: 29-34
29. MINISTERIO DE SANIDAD Y CONSUMO ESPANOL (MSC): Enfermedad de Chagas y donación de sangre, Julho 2009;41
30. CENTERS FOR DISEASE CONTROL (CDC): Blood donor screening for Chagas disease-United States 2006-2007. MMWR Morb Mortal Wkly Rep 2007;56:141-3
31. ORGANIZAÇÃO MUNDIAL DE SAÚDE, COMITÉ REGIONAL AFRICANO: Controlo da tripanossomíase humana africana, estratégia para a região africana. 2005. AFR/RC55/11.
32. ROCHA G, MARTINS A, GAMA G, BRABDÃO F, ATOUGUIA J. Possible cases of sexual and congenital transmission of sleeping sickness. Lancet 2004; 17: 363(9404):179-256
33. MORALES MA, CHICHARRO C, ARES M, et al. Molecular tracking of infections by Leishmania infantum. Trans R Soc Trop Med Hyg 2001;95:104-7
34. BIHL F, CASTELLI D, MARINCOLA F, DODD RY, BRANDER C: Transfusion-transmitted infections. J Transl Med 2007;5:25-27
35. AMORIM L. Toxoplasmose e transfusão de sangue. Rev Bras Hematol Hemoter. 2008;30(4):259-265